This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Referral criteria from primary care - gynaecomastia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team


  • GPs - When and Where to Refer (1)

    • Abnormal endocrine (hormonal) blood results - note if a marginally raised prolactin then repeat before considering referral
      • Refer to Medical Endocrinology clinic

    • Abnormal sHCG or alpha fetoprotein blood results or abnormal finding on testicular USS
      • Refer to Urology Clinic urgently

    • Referral directly to the Breast Unit
      • In the presence of the following clinical scenarios, a referral directly to the local breast unit may be considered.
        • 1. Clinical suspicion of malignancy
          • >50 year old man with unilateral firm sub-areolar mass with or without nipple discharge or with associated skin change
          • Bloody nipple discharge
          • Unilateral ulceration of the nipple
          • Urgent referral is appropriate
        • 2. Unilateral lump with
          • No obvious physiological or drug cause
          • Increased risk - family history
          • Genetic conditions e.g. Klinfelter's Syndrome
          • Urgent referral is appropriate
        • 3. Persistent painful gynaecomastia (>6 months) with normal blood tests

Reference:

  • (1) Association of Breast Surgery Summary Statement (June 2019). Investigation and management of gynaecomastia in primary and secondary care.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.